• Dendritic cell immunotherapy in uterine cancer
  • Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical intraepithelial neoplasia and cervical infection in young Japanese women: Open follow-up of a randomized clinical trial up to 4 years post-vaccination
  • A few years later: Update of the cost-effectiveness of infant pneumococcal vaccination in Dutch children
  • Pentavalent replicon vaccines against botulinum neurotoxins and tetanus toxin using DNA-based Semliki Forest virus replicon vectors
  • Annual influenza vaccination: Uptake, barriers, and enablers among student health care providers at the University of Notre Dame Australia, Fremantle
  • Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention

30 Apr 2014

Dendritic cell immunotherapy in uterine cancer

An Coosemans, Sandra Tuyaerts, Anke Vanderstraeten, Ignace Vergote, Frédéric Amant and Stefaan W Van Gool


24 Apr 2014

 Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical intraepithelial neoplasia and cervical infection in young Japanese women: Open follow-up of a randomized clinical trial up to 4 years post-vaccination

Ryo Konno, Hiroyuki Yoshikawa, Marie Okutani, Wim Quint, Pemmaraju Suryakiran, Lan Lin and Frank Struyf


8 May 2014

A few years later: Update of the cost-effectiveness of infant pneumococcal vaccination in Dutch children

Pepijn Vemer and Maarten J Postma


1 May 2014

 Pentavalent replicon vaccines against botulinum neurotoxins and tetanus toxin using DNA-based Semliki Forest virus replicon vectors

YunZhou Yu, Si Liu, Yao Ma, Zheng-Wei Gong, Shuang Wang and ZhiWei Sun


8 May 2014

Annual influenza vaccination: Uptake, barriers, and enablers among student health care providers at the University of Notre Dame Australia, Fremantle

David A Kelly, David J Macey and Donna B Mak


1 May 2014

Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention

Shayesta Dhalla and Gary Poole

Current Issue

Human Vaccines & Immunotherapeutics

August 2014

Volume 10, Issue 8

View current issue

About the cover image
Confocal images of CHO cells treated with different PTx concentrations for 12 h, negative control. For more information see Tan et al.

Open Access

Human Vaccines & Immunotherapeutics offers a highly competitive open access fee for authors who wish for free access to and distribution of published articles. Authors retain copyright of their work by utilizing a Creative Commons attribution license. Open Access papers will be submitted to PubMed Central immediately upon final publication of each issue.

Open Access Fees

Research Papers and Reports, OA fee is $750.00 USD

Reviews, Brief Reports and Short Communications, OA fee is $500.00 USD

All other types of papers, OA fee is $250.00

Journal Description

Human Vaccines & Immunotherapeutics is a unique peer-reviewed journal, focused exclusively on vaccines and immunotherapeutics for humans.

Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can help to promote interest by keeping investigators updated as well as to enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics.

Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors. Articles cover topics including but not limited to research, development, clinical, regulatory, production, epidemiology, effectiveness, health economics, use in the field, perceptions, acceptance, and safety.

Featured Special Focuses

Immunotherapy

HPV

Influenza

Recent Articles

Most Popular Downloads